Today’s AI Top Pick: ALNY
7/31/2026 · Recently Alerted Turnaround screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live ALNY price forecast →
Alnylam Pharmaceuticals is the standout buy today because every layer of the analysis agrees: deep value setup, extreme oversold conditions, powerful multi-timeframe forecast expansion, and a fresh positive earnings catalyst — all backed by best-in-class fundamentals. The stock is down 39.53% over the past year and 48.33% YTD, with RSI at 23.52 (deeply oversold) and position_in_21bar_range at just 0-7.78% across every timeframe (1h 7.78, 4h 4.92, 1d 1.28, 1wk 0). This is the definition of NOT chasing — you're buying at the low of a 33-37% drawdown, not at a top. The forecast tape is exceptional and aligned. 1h fc_short/mid/long: +48.73/+49.66/+48.93. 4h: +46.39/+56.54/+78.75. 1d: +54.08/+82.45/+70.12. The weekly is more muted (+3.42/+11.35/+10.01) which is normal for a name this beaten up, but critically no timeframe is contradicting — everything points up. Bullish_prob is 1.0 and near_term_bullish is 1.0. Fundamentally, ALNY has a PEG of 0.26 (cheapest growth on the list), ROE 96.94, salesYoY 82.57%, EPS growth next year 42.56%, and a targetUpsidePct of 95.5%. The fundamental_score is 8 (max). The news is a positive catalyst, not a landmine: the Q2 2026 earnings call highlighted Amvuttra surpassing $1B — a genuine commercial inflection for the flagship drug. This is exactly the kind of catalyst that turns a technical washout into a base. Contrast this with several "strong-forecast" alternatives that carry material news risk: FICO (worst day in 6 years after guidance cut — AVOID), FUTU (DOJ probe, HK SFC froze HK$125M client assets — cannot make this #1), NOW (1,000 layoffs and negative 1h/4h forecasts), AMSC (down 20% post-news with weekly forecasts sharply negative). Today is the right entry rather than waiting: RSI 23.52 rarely lasts, the earnings catalyst is behind us (removing a key overhang), and position at 0-8% of the 21-bar range means the risk/reward is asymmetric — there's little room down to prior lows before a bounce. Waiting for confirmation means chasing after the first 10-15% snap.
- Weekly forecast is only modestly positive (+3.42% short / +11.35% mid) — bigger daily/4h forecasts may reflect a sharp bounce that fades if weekly downtrend reasserts
- Debt/Equity of 2.76 is elevated for a biotech; any sector-wide risk-off (biotech ETF weakness) can override company-specific setup
- Perf YTD -48.33% and perf 1Y -39.53% means the tape has been a knife-catcher; a broken $200 support would open air down to $180
- PE 48.82 despite the drawdown means the stock isn't statistically "cheap" on earnings — thesis depends on continued Amvuttra ramp
- Post-earnings drift can go either way — if buy-side reaction fades in 3-5 sessions the setup weakens
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | ALNY | BUY NOW | 9.2 | Deeply oversold (RSI 23.5, pos 0-8%) with +50-80% mid/long forecasts and Amvuttra $1B catalyst just confirmed. |
| 2 | PODD | BUY NOW | 8.4 | Clean multi-tf uptrend, fundamental_score 8, near_term_bullish 1.0, mid-range entry with fc_long +64% on daily. |
| 3 | CALX | BUY NOW | 8.1 | Bottomed at 0-2% of range with fc_mid +50% on daily and recom 1.22; positive contract news. |
| 4 | TIGR | BUY PULLBACK | 7.8 | Explosive forecasts (fc_long +79% weekly) but already at 88-96% of shorter-tf ranges — wait for pullback. |
| 5 | TMDX | BUY NOW | 7.6 | Strong across all tfs (fc_mid +51.63 daily), near_term_bullish 1.0, but 23% short float adds volatility risk. |
| 6 | PDD | BUY NOW | 7.5 | Cheapest name (PE 9.5, PEG 0.63), fc_long +34% weekly, all tfs aligned, no debt. |
| 7 | GRAB | BUY NOW | 7.2 | Recom 1.23, fc_mid +31% on daily, oversold at 13-18% of range, insider selling is minor caution. |
| 8 | MIR | BUY NOW | 7.0 | Post-earnings washout at 0-10% of range with 4h/1d fc_mid +43-46%; weekly still weak. |
| 9 | ORCL | BUY PULLBACK | 6.9 | Strong 1d fc_long +42%, but 4h at 100% of range — chasing here; wait for dip to $122. |
| 10 | TMUS | BUY NOW | 6.8 | Oversold at 0-9% of range, fc_mid +20% on daily, defensive telecom with solid fundamentals. |
| 11 | STEP | BUY NOW | 6.6 | Multi-tf alignment fc_mid +22-27% short/mid, but negative operMargin and ROE cap upside. |
| 12 | AMSC | BUY PULLBACK | 6.4 | Just dropped 20% on news; wait for base — weekly forecasts sharply negative (-30 to -47%). |
| 13 | KTOS | BUY PULLBACK | 6.3 | Not enough tape data in the block, but fundamentals solid and 130% analyst upside; wait for confirmation. |
| 14 | PGY | WAIT | 6.2 | Weekly ran +60% already (pos 94.74) — extended; short-tf forecasts negative. |
| 15 | ONON | WAIT | 6.1 | 1h/4h forecasts slightly negative, mid-range position, no strong edge either direction. |
| 16 | BIRK | WAIT | 6.0 | Modest forecasts, weekly fc negative, no urgent catalyst. |
| 17 | MLCO | BUY PULLBACK | 5.9 | Weekly fc_long +42% is compelling, but daily at 98% of range — do not chase. |
| 18 | SRAD | WAIT | 5.8 | Weekly forecasts turning negative, analysts cutting PTs recently. |
| 19 | WING | BUY PULLBACK | 5.6 | 1d fc_mid +64% is big but 4h forecasts weak and weekly fc_short negative. |
| 20 | PSN | WAIT | 5.4 | Multiple analyst PT cuts in the past week; salesYoY -5.84%. |
| 21 | PLTR | WAIT | 5.2 | Weekly fc_mid/long -47/-48% is a red flag despite strong fundamentals; wait for earnings. |
| 22 | RBBN | WAIT | 5.0 | Rosenblatt just cut PT; salesYoY -7.62%; setup unclear from truncated tape. |
| 23 | SE | WAIT | 4.9 | 1h/4h forecasts negative (-12 to -15%), extended weekly (pos 88.64) — chasing. |
| 24 | SDA | AVOID | 4.5 | Micro-cap ($80M) with PE 434 and 1h forecast -17 to -24%; forecast magnitudes on weekly (+900%) are noise. |
| 25 | QTWO | WAIT | 4.4 | RSI 66.5, weekly at 100% of range, bullish_prob only 0.4 despite good news. |
| 26 | CELH | WAIT | 4.2 | 4h fc_short -13.84, earnings preview flags DECLINE in earnings — wait for Aug 6 report. |
| 27 | NOW | AVOID | 3.8 | 1,000 layoffs announced, 1h forecasts -12 to -8%, near_term_bullish 0. |
| 28 | FUTU | AVOID | 3.5 | DOJ probe + HK SFC froze HK$125M in client assets — regulatory landmine overrides bullish tape. |
| 29 | TOST | AVOID | 3.3 | RSI 70, bullish_prob 0, targetUpsidePct only 5.6%. |
| 30 | FICO | AVOID | 2.5 | Worst day in 6 years after guidance cut on 7/30 — do not catch this knife. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord